...
首页> 外文期刊>Journal of Current Ophthalmology >Sensitivity of indocyanine green angiography compared to fluorescein angiography and enhanced depth imaging optical coherence tomography during tapering and fine-tuning of therapy in primary stromal choroiditis: A case series
【24h】

Sensitivity of indocyanine green angiography compared to fluorescein angiography and enhanced depth imaging optical coherence tomography during tapering and fine-tuning of therapy in primary stromal choroiditis: A case series

机译:吲哚菁绿血管造影术与荧光素血管造影术和增强深度成像光学相干断层扫描术在原发性基质脉络膜炎的逐渐缩小和微调过程中的敏感性:一个病例系列

获取原文
   

获取外文期刊封面封底 >>

       

摘要

PurposeTo investigate indocyanine green angiography (ICGA), fluorescein angiography (FA), and enhanced depth imaging optical coherence tomography measured choroidal thickness (EDI-OCT-CT) in the follow-up of inflammatory activity in stromal choroiditis [Vogt-Koyanagi-Harada disease (VKH) and birdshot retinochoroiditis (BRC)] under treatment in order to monitor tapering of therapy or readjustment of therapy in case of subclinical disease recurrence.MethodsPatients with initial onset disease and/or treatment-naive stromal choroiditis (VKH & BRC) at entry, quiet under therapy, and having had a follow-up of at least four years monitored with dual FA and ICGA and EDI-OCT-CT measurements were analyzed retrospectively. ICGA and FA scores and EDI-OCT-CT values were correlated with therapy, and significant changes of each modality were correlated with disease evolution.ResultsOf the 31 VKH and 29 BRC patients seen from 1995 to 2017 in our center, four patients (2 VKH and 2 BRC patients) fulfilled the inclusion criteria. During tapering, two patients (both VKH) showed no significant ICGA, FA, and EDI-OCT-CT changes (mean follow-up time 5.6 years) and allowed for safe tapering. In the other two (BRC) patients (mean follow-up time 6.25 years), a total of seven significant subclinical changes were demonstrated by ICGA alone after therapy modifications due to side-effects or during attempted tapering of therapy, while FA and EDI-OCT-CT remained unchanged.ConclusionsICGA was the most sensitive monitoring modality of stromal choroiditis, able to identify subclinical recurrences following change of therapy and inversely treatment responses after readjusted therapy, events otherwise missed by FA and EDI-OCT. ICGA proved efficient for safe therapy tapering or for timely adjustment of therapy in stromal choroiditis when necessary.
机译:目的探讨在基质性脉络膜炎[Vogt-Koyanagi-Harada病]的炎症活动随访中,吲哚菁绿色血管造影(ICGA),荧光素血管造影(FA)和增强深度成像光学相干断层扫描测量脉络膜厚度(EDI-OCT-CT) (VKH)和鸟状视网膜脉络膜炎(BRC)]正在接受治疗,以监测亚临床疾病复发时治疗的逐渐减少或治疗的调整。方法初次发病和/或初治的初发性基质脉络膜炎(VKH&BRC)的患者回顾性分析了在治疗中安静,接受治疗且随访至少四年的患者,并进行了双重FA和ICGA监测,并对EDI-OCT-CT测量进行了分析。结果1995年至2017年我中心收治的31例VKH和29例BRC患者中,有4例(2 VKH)与ICGA和FA评分以及EDI-OCT-CT值与治疗相关,每种方式的显着变化与疾病进展相关。和2名BRC患者)符合纳入标准。在渐缩期间,两名患者(均为VKH)均未表现出明显的ICGA,FA和EDI-OCT-CT改变(平均随访时间为5.6年),并允许安全渐缩。在其他两名(BRC)患者(平均随访时间6.25年)中,仅因副作用而在治疗修改后或尝试减量治疗期间,仅由ICGA证实总共有七个重大的亚临床变化,而FA和EDI-结论:ICGA是间质性脉络膜炎的最敏感监测方式,能够识别出治疗改变后的亚临床复发以及调整后的治疗反应,否则FA和EDI-OCT会错过这些事件。经证明,ICGA可有效减少锥度脉络膜炎的安全治疗或在必要时及时调整治疗方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号